Search results - 36 results
Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials.
Gilham, Clare; Giorgi-Rossi, Paolo; Berkhof, Johannes; Peto, Julian; Meijer, Chris J L M; International HPV screening working group Source: Lancet, Volume 383, Issue 9916, p.524-32 (2014) Keywords: Adult ...
Accuracy of human papillomavirus testing on self-collected versus clinician-collected samples: a meta-analysis.
Screening Papillomaviridae Papillomavirus Infections Predictive Value of Tests Reproducibility of Results Self Care specimen handling Uterine Cervical Neoplasms Abstract: BACKGROUND: Screening for human ...
The future role for colposcopy in Europe.
Detection of Cancer Europe Female Humans Uterine Cervical Neoplasms Abstract: Improvements in the performance of cervical screening may be limited by the diagnostic performance of colposcopy. Nonetheless, ...
HPV testing and vaccination in Europe.
Papillomavirus DNA Tests Humans Papillomaviridae Papillomavirus Infections Papillomavirus Vaccines Uterine Cervical Neoplasms Vaccination Abstract: Current cytology-based screening has a moderate sensitivity to ...
Comprehensive control of human papillomavirus infections and related diseases.
have developed increasingly sensitive and specific molecular diagnostic tools for HPV detection for use in cervical cancer screening; and have substantially increased global awareness of HPV and its many ...
Patterns and trends in human papillomavirus-related diseases in Central and Eastern Europe and Central Asia.
75. The high cervical cancer burden is exacerbated by a lack of effective screening and an increasing risk of death from the disease among young women, as observed in Belarus, Tajikistan, Kyrgyzstan, ...
Human papillomavirus prevalence and type-distribution, cervical cancer screening practices and current status of vaccination implementation in Russian Federation, the Western countries of the former Soviet Union, Caucasus region and Central Asia.
cytology, women from the general population, cervical precancerous lesions and cervical cancer, as well as data on national policies of cervical cancer screening and HPV vaccination initiatives in these ...
Human papillomavirus prevalence and type-distribution, cervical cancer screening practices and current status of vaccination implementation in Central and Eastern Europe.
Uterine Cervical Neoplasms Vaccination Abstract: We present a review of current cervical cancer screening practices, the implementation status of vaccination against human papillomaviruses (HPV) and ...
The APTIMA HPV assay versus the Hybrid Capture 2 test in triage of women with ASC-US or LSIL cervical cytology: a meta-analysis of the diagnostic accuracy.
triage of low-grade squamous intraepithelial lesions (LSIL) detected in cervical cancer screening. In a meta-analysis, we compared the accuracy of the APTIMA HPV test, which identifies RNA of 14 high-risk ...
Evidence regarding human papillomavirus testing in secondary prevention of cervical cancer.
low-grade cytologic abnormalities; prediction of the therapeutic outcome after treatment of cervical intraepithelial neoplasia (CIN) lesions, and last not but not least, primary screening for cervical cancer ...